Recent Updates
Recently added Catalysts
BMY Positive Sentiment

Bristol Myers Squibb to Present at J.P. Morgan’s 44th Annual Healthcare Conference

Friday, January 2, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Bristol Myers Squibb (BMY) will present at the J.P. Morgan 44th Annual Healthcare Conference on January 12, 2026. The presentation will include a fireside chat starting at 7:30 a.m. PST/10:30 a.m. ET. The event will be available via webcast, with materials provided at the start and a replay accessible afterward.
Price reaction · baseline $53.94 (2025-12-31 close) · hit pre-market · 1 other BMY headline(s) in the window, move may be shared
day 0 close
-0.9%

Market Sentiment Analysis

POSITIVE FACTORS

  • Bristol Myers Squibb is actively participating in a major healthcare conference.
  • The company is committed to sharing its innovative approaches in medicine.
  • The event provides a platform for engaging with investors and stakeholders.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+20%
120-day peak, hindsight
Typical move
1.7%
average across 15 past catalysts
Lead asset
Muraglitazar
Phase 3 · Type 2 Diabetes

Full Press Release Details

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced that the company will present at J.P. Morgan’s 44thAnnual Healthcare Conference on Monday, January 12, 2026.
The company’s presentation and participation in a fireside chat will begin at 7:30 a.m. PST/10:30 a.m. ET.
The event will be webcast simultaneously athttp://investor.bms.com, with materials related to the presentation available at the start of the live webcast. A replay and archived edition of the presentation will be available following the conclusion of the event.
About Bristol Myers Squibb: Transforming Patients’ Lives Through ScienceAt Bristol Myers Squibb, our mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We are pursuing bold science to define what’s possible for the future of medicine and the patients we serve. For more information, visit us atBMS.comand follow us onLinkedIn,X,YouTube,FacebookandInstagram.
corporatefinancial-news

Frequently Asked Questions

When will Bristol Myers Squibb present at the conference?

Bristol Myers Squibb will present on January 12, 2026.

What time does the presentation start?

The presentation begins at 7:30 a.m. PST/10:30 a.m. ET.

How can I watch the presentation?

The event will be webcast live at investor.bms.com.

Will there be a replay of the presentation?

Yes, a replay will be available after the event concludes.

ShareAdd on Google
Tags: BMY Viatris Investor Conferences Healthcare J.P. Morgan healthcare conference Bristol Myers Squibb presentation
Last updated: Jan 2, 2026

Biotech snapshot

Cash runway
$11464M liquidity · $0M/mo burn
Low dilution risk
Lead asset
MuraglitazarPhase 3
Type 2 Diabetes →

Catalyst track record

+20%
best trade around BMY's most recent catalyst

Peak hindsight return over a 120-day window, across 15 tracked FDA/PDUFA catalysts for BMY.

See every catalyst's timing & PoA →